Riskpilot← Back to searchSign inGet full accessMESNA HUDKLINIKK AS
ASActiveOrg 916928521Elvegata 19, 2609 LillehammerMedical specialists activities · NACE 8622Est. 20167 employees
Revenue 2024
NOK 11,2M
-1% vs 2023
EBITDA margin
60.4%
+18% vs 2023
Equity ratio
0.7%
Financial strength
Net profit 2024
NOK 5,2M
+19% vs 2023
| Revenue | NOK 11,2M | -1% |
| EBITDA | NOK 6,8M | +18% |
| Net profit | NOK 5,2M | +19% |
| Total assets | NOK 8,2M | +25% |
| Equity | NOK 59K | -93% |
| Employees | 7 | — |
Legal name
MESNA HUDKLINIKK AS
Org number
916928521
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
4. april 2016
Share capital
NOK 30 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Selskapets virksomhet er å drive hudklinikk og spesialisert legetjeneste innen hudpleie, samt virksomhet som naturlig faller inn under dette.
Address
Elvegata 19, 2609 Lillehammer
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 10 392 | 8 155 | 10 260 | 11 246 | 11 185 |
| Staff expenses | −1 966 | −1 656 | −1 794 | −3 586 | −2 799 |
| EBITDA | 7 227 | 4 277 | 4 644 | 5 716 | 6 751 |
| Depreciation & amort. | −305 | −208 | −40 | −83 | −56 |
| EBIT | 6 922 | 4 069 | 4 604 | 5 632 | 6 695 |
| Net financials | 1 | −50 | 2 | −14 | −7 |
| Profit before tax | 6 924 | 4 019 | 4 606 | 5 619 | 6 688 |
| Tax | 1 525 | 886 | 1 015 | 1 237 | 1 473 |
| Net profit | 5 399 | 3 132 | 3 590 | 4 382 | 5 215 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 475 | 6 926 | 5 417 | 6 559 | 8 186 |
| Equity | 653 | 30 | 2 924 | 843 | 59 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 822 | 6 896 | 2 493 | 5 716 | 8 127 |
| Total debt | 4 822 | 6 896 | 2 493 | 5 716 | 8 127 |
EBITDA margin
60.4%
This company
15.8%
Market median
+282% vs market
20202024
Equity ratio
0.7%
This company
38.2%
Market median
-98% vs market
20202024
Return on equity
8881.8%
This company
18.4%
Market median
+48171% vs market
20202024
Net profit margin
46.6%
This company
8.1%
Market median
+475% vs market
20202024
Asset turnover
1.37×
This company
1.12×
Market median
+22% vs market
20202024
Debt / equity
138.41×
This company
0.62×
Market median
-22224% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (2) | ||
| Chairman | 2016 – 2022 | |
| Board of Directors | 2016 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mesna Hudklinikk Holding As
MESNA HUDKLINIKK AS Board members of MESNA HUDKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Florian Gatty | Chairman | 0 companies |
| Tanja Gatty | Board of Directors | 0 companies |
| Peter John Morrison | Board of Directors | 0 companies |
| Kirsten Eva Annedore Morrison | Chairman | 0 companies |